1999PharmacopsychiatryRequires access

Citalopram, a Selective Serotonin Reuptake Inhibitor, Improves Symptoms of Friedreich's Ataxia

Albert S. Rohr, K. Eichler, N. Hafezi-Moghadam

Open publisher page 7 citations

Abstract

Two patients (siblings) with Friedreich's ataxia showed improvement in their clinical symptoms--particularly spasticity and cardiac symptoms--after treatment with the selective serotonin reuptake inhibitor citalopram.

About this research paper

What this paper is about

Two patients (siblings) with Friedreich's ataxia showed improvement in their clinical symptoms--particularly spasticity and cardiac symptoms--after treatment with the selective serotonin reuptake inhibitor citalopram.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Two patients (siblings) with Friedreich's ataxia showed improvement in their clinical symptoms--particularly spasticity and cardiac symptoms--after treatment with the selective serotonin reuptake inhibitor citalopram.

Key concepts: Citalopram, Serotonin reuptake inhibitor, Ataxia, Reuptake inhibitor, Serotonin Uptake Inhibitors, Fluoxetine, Serotonin, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Citalopram, a Selective Serotonin Reuptake Inhibitor, Improves Symptoms of Friedreich's Ataxia — Research Paper | ScholarLens